<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Exp Biol Med (Maywood)</journal-id>
<journal-id journal-id-type="iso-abbrev">Exp. Biol. Med. (Maywood)</journal-id>
<journal-id journal-id-type="publisher-id">EBM</journal-id>
<journal-id journal-id-type="hwp">spebm</journal-id>
<journal-title-group>
<journal-title>Experimental Biology and Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1535-3702</issn>
<issn pub-type="epub">1535-3699</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30704299</article-id>
<article-id pub-id-type="pmc">6547010</article-id>
<article-id pub-id-type="doi">10.1177/1535370219826070</article-id>
<article-id pub-id-type="publisher-id">10.1177_1535370219826070</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Minireview</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>How diet and the microbiome shape health or contribute to disease: A mini-review of current models and clinical studies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zangara</surname>
<given-names>Megan T</given-names>
</name>
<xref ref-type="aff" rid="aff1-1535370219826070">1</xref>
<xref ref-type="aff" rid="aff2-1535370219826070">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-6745-9487</contrib-id>
<name>
<surname>McDonald</surname>
<given-names>Christine</given-names>
</name>
<xref ref-type="corresp" rid="corresp1-1535370219826070"></xref>
<xref ref-type="aff" rid="aff1-1535370219826070">1</xref>
<xref ref-type="aff" rid="aff2-1535370219826070">2</xref>
</contrib>
<aff id="aff1-1535370219826070">
<label>1</label>Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA</aff>
<aff id="aff2-1535370219826070">
<label>2</label>Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve, Cleveland, OH 44106, USA</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>von Recum</surname>
<given-names>Horst</given-names>
</name>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-1535370219826070">Christine McDonald. Email: <email>mcdonac2@ccf.org</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2019</year>
</pub-date>
<volume>244</volume>
<issue>6</issue>
<issue-title>Thematic Issue: Microbiome in Healthcare and Medicine</issue-title>
<fpage>484</fpage>
<lpage>493</lpage>
<permissions>
<copyright-statement>© 2019 by the Society for Experimental Biology and Medicine</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder content-type="society">The Society for Experimental Biology and Medicine</copyright-holder>
</permissions>
<abstract abstract-type="short">
<p>The human gut microbiome is a complex ecosystem of commensal microorganisms that help to shape host development and health. Host diet directly influences not only the composition, but also the function of the microbiome. In turn, the microbiome impacts the health of the host through production of metabolites from ingested food. Studies of this host-microbe relationship have recently enhanced our understanding of disease development and pathogenesis, and are now being targeted to combat disease symptoms and promote health. For example, dietary shifts to a high-fat, high-sugar “Western diet” drives microbiome dysbiosis in several disease models, which correlates with disease severity. Reintroduction of fiber, increased antioxidants, or decreases in fat and sugar intake helps to restore microbial balance to a healthier composition and often improves disease parameters. Analyses of microbiome-produced metabolites emphasize that understanding how diet shifts the function of the microbiome may be of critical importance for therapeutic targeting of the host-microbe relationship to promote health. In this mini-review, we discuss what is known about the three-way relationship between diet, the microbiome, and disease utilizing animal models, as well as the findings from human clinical trials of dietary therapeutics.</p>
<sec id="sec1-1535370219826070">
<title>Impact statement</title>
<p>The studies reviewed in this article combine diet in the context of disease progression or treatment with analysis of the microbiome. First, we present findings on how diet manipulation impacts the microbiome and disease pathogenesis in a broad variety of rodent models of disease. Then, we describe results from clinical trials that are using diet therapies to attempt to shift the microbiome and treat disease symptoms. Finally, we discuss what these studies have taught us about the influence of the microbiome of disease and health states and highlight the evidence suggesting that dietary modulation of the microbiome is an emerging therapeutic option for a variety of different diseases.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Diet</kwd>
<kwd>microbiome</kwd>
<kwd>disease</kwd>
<kwd>inflammation</kwd>
<kwd>immunonutrition</kwd>
<kwd>genetics</kwd>
</kwd-group>
<funding-group>
<award-group id="award1-1535370219826070">
<funding-source id="funding1-1535370219826070">
<institution-wrap>
<institution>Congressionally Directed Medical Research Programs</institution>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000090</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="funding1-1535370219826070">W81XWH-16-1-0439</award-id>
</award-group>
<award-group id="award2-1535370219826070">
<funding-source id="funding2-1535370219826070">
<institution-wrap>
<institution>National Institute of General Medical Sciences</institution>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000057</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="funding2-1535370219826070">T32GM088088</award-id>
<award-id rid="funding2-1535370219826070">UL1TR000439</award-id>
</award-group>
<award-group id="award3-1535370219826070">
<funding-source id="funding3-1535370219826070">
<institution-wrap>
<institution>CURE for IBD</institution>
<institution-id institution-id-type="FundRef"></institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="award4-1535370219826070">
<funding-source id="funding4-1535370219826070">
<institution-wrap>
<institution>Guy &amp; Mary Jo McDonald</institution>
<institution-id institution-id-type="FundRef"></institution-id>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>